Cargando…
A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected cells persist for decades on ART and viremia returns if ART is stopped. Persistence has been attributed to viral replication in an ART sanctuary and long-lived and/or proliferating latently infected ce...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240116/ https://www.ncbi.nlm.nih.gov/pubmed/30446650 http://dx.doi.org/10.1038/s41467-018-06843-5 |
_version_ | 1783371576944623616 |
---|---|
author | Reeves, Daniel B. Duke, Elizabeth R. Wagner, Thor A. Palmer, Sarah E. Spivak, Adam M. Schiffer, Joshua T. |
author_facet | Reeves, Daniel B. Duke, Elizabeth R. Wagner, Thor A. Palmer, Sarah E. Spivak, Adam M. Schiffer, Joshua T. |
author_sort | Reeves, Daniel B. |
collection | PubMed |
description | Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected cells persist for decades on ART and viremia returns if ART is stopped. Persistence has been attributed to viral replication in an ART sanctuary and long-lived and/or proliferating latently infected cells. Using ecological methods and existing data, we infer that >99% of infected cells are members of clonal populations after one year of ART. We reconcile our results with observations from the first months of ART, demonstrating mathematically how a fossil record of historic HIV replication permits observed viral evolution even while most new infected cells arise from proliferation. Together, our results imply cellular proliferation generates a majority of infected cells during ART. Therefore, reducing proliferation could decrease the size of the HIV reservoir and help achieve a functional cure. |
format | Online Article Text |
id | pubmed-6240116 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-62401162018-11-19 A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation Reeves, Daniel B. Duke, Elizabeth R. Wagner, Thor A. Palmer, Sarah E. Spivak, Adam M. Schiffer, Joshua T. Nat Commun Article Antiretroviral therapy (ART) suppresses viral replication in people living with HIV. Yet, infected cells persist for decades on ART and viremia returns if ART is stopped. Persistence has been attributed to viral replication in an ART sanctuary and long-lived and/or proliferating latently infected cells. Using ecological methods and existing data, we infer that >99% of infected cells are members of clonal populations after one year of ART. We reconcile our results with observations from the first months of ART, demonstrating mathematically how a fossil record of historic HIV replication permits observed viral evolution even while most new infected cells arise from proliferation. Together, our results imply cellular proliferation generates a majority of infected cells during ART. Therefore, reducing proliferation could decrease the size of the HIV reservoir and help achieve a functional cure. Nature Publishing Group UK 2018-11-16 /pmc/articles/PMC6240116/ /pubmed/30446650 http://dx.doi.org/10.1038/s41467-018-06843-5 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Reeves, Daniel B. Duke, Elizabeth R. Wagner, Thor A. Palmer, Sarah E. Spivak, Adam M. Schiffer, Joshua T. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title_full | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title_fullStr | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title_full_unstemmed | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title_short | A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation |
title_sort | majority of hiv persistence during antiretroviral therapy is due to infected cell proliferation |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240116/ https://www.ncbi.nlm.nih.gov/pubmed/30446650 http://dx.doi.org/10.1038/s41467-018-06843-5 |
work_keys_str_mv | AT reevesdanielb amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT dukeelizabethr amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT wagnerthora amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT palmersarahe amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT spivakadamm amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT schifferjoshuat amajorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT reevesdanielb majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT dukeelizabethr majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT wagnerthora majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT palmersarahe majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT spivakadamm majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation AT schifferjoshuat majorityofhivpersistenceduringantiretroviraltherapyisduetoinfectedcellproliferation |